SCHEMBL6815409

SCHEMBL6815409

O=C(NC(c1ccccc1)c1ccccc1)C(Cc1csc2ccccc12)NS(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 4/20 0.45
MMP8 P22894 4/20 0.45
MMP2 P08253 3/20 0.45
MMP1 P03956 2/20 0.45
CTSL P07711 1/20 0.44
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
MMP14 P50281 2/20 0.41
MMP3 P08254 1/20 0.41
MMP25 Q9NPA2 1/20 0.41
NPY5R Q15761 1/20 0.40
KCNA5 P22460 2/20 0.39
F2 P00734 4/20 0.37
F10 P00742 2/20 0.37
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37
PLAT P00750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6815411 1.00 MMP9 (0.45) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6818700 0.85 HPN (0.45) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6818706 0.85 HPN (0.45) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6814338 0.84 CTSS (0.42) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6814340 0.84 CTSS (0.42) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6819150 0.81 CTSL (0.43) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6818927 0.81 CTSL (0.43) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6819859 0.81 MMP2 (0.51) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6819854 0.81 MMP2 (0.51) MMP9MMP8MMP2MMP1CTSL
SCHEMBL6818472 0.80 MMP2 (0.49) MMP9MMP8MMP2MMP1CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004020402-A1 SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE DE NOVO PHARMACEUTICALS LIMITED (GB) 2004-03-11 WO claimed
WO-2004020402-A1 SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE DE NOVO PHARMACEUTICALS LIMITED (GB) 2004-03-11 WO disclosed